Are you a new member? Sign up now
Login area
| Sign up
close
SKYRIZI - 75mg - 2+2alcohol pads
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AC18 | BioTech | Risankizumab - 75mg | 10195 | 143719/1 | SKYRIZI | 75mg | 2+2alcohol pads | Injectable solution | SC | Interpharma S.A.L. | Boehringer Ingelheim Pharma GmbH & Co KG | Germany | 194,911,251 L.L | 2.44 | E2 | Abbvie Deutschland GmbH & Co KG | Germany | 2/5/2024 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AC18 | BioTech | Risankizumab - 150mg | 11112 | 103421/1 | SKYRIZI | 150mg | 1 | Injectable solution | SC | Interpharma S.A.L. | Abbvie Biotechnology Ltd | USA | 194,911,251 L.L | 2.44 | E2 | Abbvie Deutschland GmbH & Co KG | Germany | 2/5/2024 | 0 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024